Alaunos Therapeutics | ZIOP - Actif À Court Terme





Actif À Court Terme Changement Date
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Baxter International USD 6.85B 25M 2026-03
Biogen USD 9.19B 216.3M 2026-03
Bioline Rx USD 21.58M 2.1M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Celltrion KRW 481.57B 10.97B 2026-03
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Curis USD 6.92M 7.5M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
J&J USD 59.77B 601M 2026-06
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Merck USD 35.02B 8.5B 2026-03
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pfizer USD 42.82B 76M 2026-03
Pharma Mar EUR 273.45M 9.96M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Qiagen NV USD 1.54B 454.82M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sartorius EUR 1.64B 280M 2026-06
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
TG Therapeutics USD 1.09B 456.2M 2026-03
Tilray USD 729.32M 28.18M 2025-09
Verastem USD 223.41M 69.36M 2025-12
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03